Scinovex
articleTop 1% cited

Mutations in PCSK9 cause autosomal dominant hypercholesterolemia

Nature Genetics · 2003 · Vol. 34(2) · pp. 154–156
Marianne AbifadelMathilde VarretJean‐Pierre RabèsDelphine AllardKhadija OuguerramMartine DevillersCorinne CruaudSuzanne BenjannetL. Alexandra WickhamD. ErlichAurélie DerréLudovic VillégerMichel FarnierIsabel BeuclerÉric BruckertJean ChambazB. ChanuJean‐Michel LecerfGérald LucPhilippe MoulinJean WeissenbachAnnik PratMichel KrempfClaudine JunienNabil G. SeidahCathérine Boileau
Cholesterol and Lipid MetabolismLipoproteins and Cardiovascular HealthProtein Kinase Regulation and GTPase SignalingPCSK9KexinBiologyProprotein convertaseApolipoprotein BLDL receptorFamilial hypercholesterolemiaLipoproteinLocus (genetics)Subtilisin

MeSH terms

Proprotein Convertase 9Chromosomes, Human, Pair 1FemaleGenes, DominantHumansHyperlipoproteinemia Type IIGenetic LinkageLiverMaleMutationPedigreeSerine EndopeptidasesAmino Acid SubstitutionProprotein Convertases

Funding

  • Pfizer
  • Institut National de la Santé et de la Recherche Médicale
  • Fondation de France
Citation Network

How this paper connects to the literature. Drag to explore, click any node to open that paper.